Teva Pharmaceutical Industries (TEVA) Long-Term Investments (2009 - 2012)
Teva Pharmaceutical Industries' Long-Term Investments was $1.21 billion in Q3 2012, up 105.1% from $589 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Long-Term Investments (2009 - 2012) Analysis & Trends
At the end of FY2011, Long-Term Investments at Teva Pharmaceutical Industries came in at $991 million, up 56.8% from FY2010.
- In earlier years, Long-Term Investments was $632 million in FY2010 (+18.4%) and $534 million in FY2009.
- The Q3 2012 figure marks the highest quarterly Long-Term Investments in data going back to Q1 2009.
- Compared with a year earlier, Long-Term Investments has increased for four straight quarters, with growth averaging 37.3% over the last eight quarters.
- The best year-over-year quarter for Long-Term Investments over five years was Q3 2012 (growth of 105.1%); the worst was Q3 2011 (a decline of 13.4%).
- Per Business Quant data, TEVA's Long-Term Investments in the three quarters before Q3 2012 was $1.12 billion (Q2 2012), $1.04 billion (Q1 2012) and $991 million (Q4 2011).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Teva Pharmaceutical Industries | 49.58 Bn | 34.55 Bn | 2.44 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 1.21 Bn |
| Jun 30, 2012 | 1.12 Bn |
| Mar 31, 2012 | 1.04 Bn |
| Dec 31, 2011 | 991.00 Mn |
| Sep 30, 2011 | 589.00 Mn |
| Jun 30, 2011 | 650.00 Mn |
| Mar 31, 2011 | 671.00 Mn |
| Dec 31, 2010 | 632.00 Mn |
| Sep 30, 2010 | 680.00 Mn |
| Jun 30, 2010 | 628.00 Mn |
| Mar 31, 2010 | 665.00 Mn |
| Dec 31, 2009 | 534.00 Mn |
| Sep 30, 2009 | 484.00 Mn |
| Jun 30, 2009 | 459.00 Mn |
| Mar 31, 2009 | 406.00 Mn |
API Access
Teva Pharmaceutical Industries Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();